跳至主要内容
临床试验/NCT06370481
NCT06370481招募中不适用

HIV, Equity, and Addiction Training (HEAT) Program

University of Alabama at Birmingham2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2026年1月29日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
30
试验地点
2
主要终点
Percent of participants who have a follow-up healthcare visit

研究概览

简要总结

This project is a pilot study to determine the feasibility and acceptability of a telemedicine intervention for substance use disorder service delivery in diverse people living with HIV in Alabama.

详细描述

The contemporary drug crisis and the COVID-19 pandemic have exposed the complex syndemics of addiction and infectious diseases: rising rates of substance use disorder (SUD) have outpaced our ability to respond with a limited healthcare workforce and public health capacity. SUD is increasing in those living with and at risk for HIV, and infectious consequences of SUD, like hepatitis C, have continued, unmitigated, in rural parts of the U.S. where many states lack Medicaid expansion, syringe service programs, and public health infrastructure to respond to the drug crisis and comorbid infections. Systemic racism and regressive policies in the Deep South criminalize people who use drugs, creating additional barriers to care, HIV prevention, and addiction treatment. As a result, people who use drugs rarely receive comprehensive addiction and HIV treatment. Yet telemedicine has the potential to overcome these barriers and bypass the constraints of a brick-and-mortar clinic to link vulnerable people, including those with HIV, to care. Although telemedicine has become mainstream in recent years, few studies have evaluated telemedicine for SUD in the Deep South from the perspective of patients and providers.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Receiving services at HIV clinics in Alabama
  • Reported opioid and/or stimulant misuse
  • 18 years of age or older

排除标准

  • Receipt of SUD clinical care other than through HIV provider/clinic in the last 3 months
  • Inability to engage in interviews independently without support (e.g., cognitive impairment)
  • Currently psychotic
  • Actively suicidal: presents with a suicide attempt or suicidal ideation

研究组 & 干预措施

Patients living with HIV and substance use

Experimental

Patients living with HIV and substance use, aged 18 and over. These participants are receiving services at HIV clinics in Alabama and must have reported opioid and/or stimulant misuse.

干预措施: Telemedicine (Other)

Patients living with HIV and substance use

Experimental

Patients living with HIV and substance use, aged 18 and over. These participants are receiving services at HIV clinics in Alabama and must have reported opioid and/or stimulant misuse.

干预措施: Standard of care (Other)

结局指标

主要结局

Percent of participants who have a follow-up healthcare visit

时间窗: 1 month, 2 months, 3 months

Follow up visit for care (either telemedicine or in person)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ellen Eaton

Associate Professor

University of Alabama at Birmingham

研究点 (2)

Loading locations...

相似试验